ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284 | -17.9% | 13,605 | -5.9% | 0.00% | 0.0% |
| Q2 2023 | $346 | +29.6% | 14,455 | +1.7% | 0.00% | 0.0% |
| Q1 2023 | $267 | +20.8% | 14,207 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $221 | -99.9% | 13,930 | +6.6% | 0.00% | 0.0% |
| Q3 2022 | $213,000 | +12.1% | 13,065 | -3.4% | 0.00% | – |
| Q2 2022 | $190,000 | -41.5% | 13,523 | +0.7% | 0.00% | -100.0% |
| Q1 2022 | $325,000 | -0.9% | 13,426 | -4.5% | 0.00% | 0.0% |
| Q4 2021 | $328,000 | +37.8% | 14,053 | -2.2% | 0.00% | 0.0% |
| Q3 2021 | $238,000 | -37.0% | 14,372 | -7.4% | 0.00% | 0.0% |
| Q2 2021 | $378,000 | -6.4% | 15,513 | -1.0% | 0.00% | 0.0% |
| Q1 2021 | $404,000 | -52.1% | 15,663 | -0.9% | 0.00% | -66.7% |
| Q4 2020 | $844,000 | +32.9% | 15,798 | +2.6% | 0.00% | +50.0% |
| Q3 2020 | $635,000 | -7.4% | 15,405 | +8.7% | 0.00% | -33.3% |
| Q2 2020 | $686,000 | +10.3% | 14,166 | -3.9% | 0.00% | 0.0% |
| Q1 2020 | $622,000 | -0.2% | 14,741 | +1.1% | 0.00% | +50.0% |
| Q4 2019 | $623,000 | +34.0% | 14,581 | +12.8% | 0.00% | 0.0% |
| Q3 2019 | $465,000 | +26.4% | 12,931 | -6.1% | 0.00% | 0.0% |
| Q2 2019 | $368,000 | -0.8% | 13,777 | -0.5% | 0.00% | 0.0% |
| Q1 2019 | $371,000 | +64.9% | 13,846 | -0.8% | 0.00% | +100.0% |
| Q4 2018 | $225,000 | -22.4% | 13,956 | -0.1% | 0.00% | 0.0% |
| Q3 2018 | $290,000 | +40.8% | 13,970 | +3.7% | 0.00% | 0.0% |
| Q2 2018 | $206,000 | -34.4% | 13,467 | -3.7% | 0.00% | -50.0% |
| Q1 2018 | $314,000 | – | 13,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |